Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets
Funding from MassMutual Ventures, SEEDS Capital, Exfinity Ventures BOSTON, Jan. 19, 2023 /PRNewswire/ -- Qritive (www.qritive.com), a leading healthcare AI startup has announced that they have raised $7.5M in a funding round led by MassMutual Ventures, supported by SEEDS Capital, the investment arm of Enterprise Singapore, and Exfinity Venture Partners. Qritive will use this new capital to drive geographical...
Everise Repositions Branding to Cement Evolution as End-to-End Customer Service Player
Launches new corporate slogan "Champions of customer happiness" and brand video PLANTATION, Fla., Jan. 18, 2023 /PRNewswire/ -- Leading customer service company Everise announced today the launch of its new brand repositioning, which includes a refreshed visual identity and the new brand tagline, "Champions of Customer Happiness". As of January 2023,...
Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New...
ROCKVILLE, Md. and SUZHOU, China, Jan. 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, today announced that, five products (including new indications) of the company have been included in the updated National Reimbursement...
Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes – Findings to be Presented at ASCO GI 2023
Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highlight the effectiveness of Lunit SCOPE IO as a biomarker to predict treatment outcomes in liver and colon cancer SEOUL, South Korea, Jan. 18, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ)...
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Nuvaxovid™ (NVX-CoV2373) for...
NetApp Applauded by Frost & Sullivan for Addressing Complex and Constantly Evolving Healthcare and Life Sciences Challenges With Its Cloud Services
The NetApp Healthcare Cloud Services simplify data architecture, improve data mobility, lower cloud costs, increase data protection, and streamline data management. SAN ANTONIO, Jan. 18, 2023 /PRNewswire/ -- Frost & Sullivan recently analyzed the healthcare cloud industry and, based on its findings, recognizes NetApp with the 2022 Global Technology Innovation Leadership Award. The company is a leading global platform-as-a-service...
Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services
EAST RUTHERFORD, N.J., Jan. 18, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to...
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS
Newly merged organization brings together innovative neurodiagnostic and neuromonitoring solutions and experienced teams to offer a broader portfolio of products, services and support to customers worldwide. MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory...
ASG Superconductors and Siemens Healthineers join forces to deliver 10.5T Ultra High Field MRI Systems for ground-breaking brain research
GENOA, Italy, Jan. 18, 2023 /PRNewswire/ -- ASG Superconductors (ASG) and Siemens Healthineers signed a partnership agreement to synergistically develop UHF MRI systems of unprecedented dependability for ground-breaking brain research. ASG SUPERCONDUCTORS AND SIEMENS HEALTHINEERS JOIN FORCES TO DELIVER 10.5T ULTRA HIGH FIELD MRI SYSTEMS FOR GROUND-BREAKING BRAIN RESEARCH ...
WFH Gene Therapy Registry: now live!
MONTREAL, Jan. 18, 2023 /PRNewswire/ -- To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (GTR). The launch of...
